ZENTEK LTD (ZEN.CA) Stock Fundamental Analysis

Canada TSX Venture Exchange TSX-V:ZEN • CA98942X1024

0.9 CAD
-0.03 (-3.23%)
Last: Feb 9, 2026, 07:00 PM
Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ZEN. ZEN was compared to 15 industry peers in the Health Care Equipment & Supplies industry. Both the profitability and financial health of ZEN have multiple concerns. While showing a medium growth rate, ZEN is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • In the past year ZEN has reported negative net income.
  • In the past year ZEN has reported a negative cash flow from operations.
  • In the past 5 years ZEN always reported negative net income.
  • ZEN had a negative operating cash flow in each of the past 5 years.
ZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFZEN.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -10M -20M -30M

1.2 Ratios

  • The Return On Assets of ZEN (-48.58%) is better than 73.33% of its industry peers.
  • ZEN's Return On Equity of -70.13% is amongst the best of the industry. ZEN outperforms 86.67% of its industry peers.
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROIC N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ZEN.CA Yearly ROA, ROE, ROICZEN.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 -50 -100 -150 -200 -250

1.3 Margins

  • ZEN has a worse Gross Margin (48.67%) than 60.00% of its industry peers.
  • The Profit Margin and Operating Margin are not available for ZEN so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 48.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
ZEN.CA Yearly Profit, Operating, Gross MarginsZEN.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -50K -100K -150K

3

2. Health

2.1 Basic Checks

  • ZEN does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for ZEN has been increased compared to 1 year ago.
  • The number of shares outstanding for ZEN has been increased compared to 5 years ago.
  • The debt/assets ratio for ZEN has been reduced compared to a year ago.
ZEN.CA Yearly Shares OutstandingZEN.CA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M 100M
ZEN.CA Yearly Total Debt VS Total AssetsZEN.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M 40M

2.2 Solvency

  • An Altman-Z score of 2.57 indicates that ZEN is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • ZEN's Altman-Z score of 2.57 is amongst the best of the industry. ZEN outperforms 100.00% of its industry peers.
  • ZEN has a Debt/Equity ratio of 0.15. This is a healthy value indicating a solid balance between debt and equity.
  • ZEN's Debt to Equity ratio of 0.15 is amongst the best of the industry. ZEN outperforms 86.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Altman-Z 2.57
ROIC/WACCN/A
WACC8.94%
ZEN.CA Yearly LT Debt VS Equity VS FCFZEN.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10M -10M 20M 30M 40M

2.3 Liquidity

  • A Current Ratio of 0.79 indicates that ZEN may have some problems paying its short term obligations.
  • With a Current ratio value of 0.79, ZEN perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
  • A Quick Ratio of 0.53 indicates that ZEN may have some problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 0.53, ZEN is in line with its industry, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.79
Quick Ratio 0.53
ZEN.CA Yearly Current Assets VS Current LiabilitesZEN.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M

4

3. Growth

3.1 Past

  • ZEN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 26.08%, which is quite impressive.
  • ZEN shows a strong growth in Revenue. In the last year, the Revenue has grown by 2223.10%.
  • Measured over the past years, ZEN shows a very strong growth in Revenue. The Revenue has been growing by 35.95% on average per year.
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
ZEN.CA Yearly Revenue VS EstimatesZEN.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 5M 10M
ZEN.CA Yearly EPS VS EstimatesZEN.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2023 2024 -0.05 -0.1 -0.15

0

4. Valuation

4.1 Price/Earnings Ratio

  • ZEN reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ZEN.CA Price Earnings VS Forward Price EarningsZEN.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ZEN.CA Per share dataZEN.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.05 -0.05 0.1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for ZEN!.
Industry RankSector Rank
Dividend Yield 0%

ZENTEK LTD

TSX-V:ZEN (2/9/2026, 7:00:00 PM)

0.9

-0.03 (-3.23%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-12
Earnings (Next)02-11
Inst Owners1.71%
Inst Owner ChangeN/A
Ins Owners0.78%
Ins Owner ChangeN/A
Market Cap96.58M
Revenue(TTM)915.30K
Net Income(TTM)-8.20M
Analysts84.44
Price TargetN/A
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 105.52
P/FCF N/A
P/OCF N/A
P/B 8.26
P/tB 8.26
EV/EBITDA N/A
EPS(TTM)-0.08
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.06
FCFYN/A
OCF(TTM)-0.05
OCFYN/A
SpS0.01
BVpS0.11
TBVpS0.11
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -48.58%
ROE -70.13%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 48.67%
FCFM N/A
ROA(3y)-49.9%
ROA(5y)-62.95%
ROE(3y)-57.84%
ROE(5y)-109.36%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.15
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 88.48%
Cap/Sales 54.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.79
Quick Ratio 0.53
Altman-Z 2.57
F-Score4
WACC8.94%
ROIC/WACCN/A
Cap/Depr(3y)182.79%
Cap/Depr(5y)454.82%
Cap/Sales(3y)1708.52%
Cap/Sales(5y)12638%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)26.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%23.75%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)2223.1%
Revenue growth 3Y35.96%
Revenue growth 5YN/A
Sales Q2Q%-60.51%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.82%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y49.7%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y49.4%
OCF growth 3YN/A
OCF growth 5YN/A

ZENTEK LTD / ZEN.CA FAQ

Can you provide the ChartMill fundamental rating for ZENTEK LTD?

ChartMill assigns a fundamental rating of 2 / 10 to ZEN.CA.


What is the valuation status of ZENTEK LTD (ZEN.CA) stock?

ChartMill assigns a valuation rating of 0 / 10 to ZENTEK LTD (ZEN.CA). This can be considered as Overvalued.


Can you provide the profitability details for ZENTEK LTD?

ZENTEK LTD (ZEN.CA) has a profitability rating of 1 / 10.